Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 666-673

  Huang, Mingxing ^a   Jie, Yusheng ^a   Shi, Hong ^a   Li, Xinhua ^a   Li, Xiangyong ^a   Wu, Yuankai ^a   Lin, Guoli ^a   Chong, Yutian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Chronic hepatitis B; ETV; TDF; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATINE KINASE; ENTECAVIR; TENOFOVIR DISOPROXIL; VIRUS DNA;

ADULT; AGED; ARTICLE; CHINA; CREATINE KINASE BLOOD LEVEL; DNA REPLICATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SIDE EFFECT;

HEPATITIS B VIRUS;

EID: 84923010264     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
2. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH; REVEAL-HBV Study Group.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-85.
4. Gerada J, Borg E, Formosa D, Magro R, Pocock J. Tenofovir as rescue therapy following clinical failure to Lamivudine in severe acute hepatitis B. Mediterr J Hematol Infect Dis 2013; 5: e2013035.
5. Keskin O, Ormeci AC, Baran B, Kabaçam G, Tüzün A, Karatayli E, Akyüz F, Karatayli S, Bozdayi AM, Onel D, Badur S, Idilman R, Kaymakoglu S, Yurdaydin C. Efficacy of tenofovir in adefovir-experienced patients compared to treat-ment-naive patients with chronic hepatitis B. Antivir Ther 2014; 19: 543-50.
6. Fung S, Kwan P, Fabri M, Horban A, Pelemis M, Hann HW, Gurel S, Caruntu FA, Flaherty JF, Massetto B, Dinh P, Corsa A, Subramanian GM, McHutchison JG, Husa P, Gane E. Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B. Gastroenterology 2014; 146: 980-988.
7. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J Hepatol 2011; 19: 13-24.
8. Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008; 359: 2442-55.
9. Doğan ÜB, Kara B, Gümürdülü Y. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B. Turk J Gastroenterol 2012; 23: 247-52.
10. Lampertico P, Soffredini R, Viganò M, Yurdaydin C, Idilman R, Papatheodoris G, Margheriti K, Buti M, Esteban R, Zaltron S, Vavassori A, Carosi G, Minola E, Vinci M, Pinzello G, Giorgini A, Zuin M, Salmi A, Del Poggio P, De Filippi F, Bruno S, Pasulo L, Fagiuoli S, Andreoletti M, Colli A, Fumagalli Maldini F, Milanese M, Colombo AE, Bellati GA, Angeli E, Angeli E, Gubertini G, Rizzardini G, Fasano M, Santantonio T, Terreni N, Spinzi G, Facchetti F, Invernizzi F, Colombo M. 2 year effectiveness and safety of tenofovir in 302 NUC-naïve patients with chronic hepatitis B: a multicenter European study in clinical practice. Hepatology 2011; 54 Suppl 1: Abstract 1433.
11. Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Gurel S, Snow-Lampart A, Borroto-Esoda K, Mondou E, Anderson J, Sorbel J, Rousseau F. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology 2011; 140: 132-143.